Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry

Thomas, D; Harvey, ES; McDonald, VM; Stevens, S; Upham, JW; Katelaris, CH; Kritikos, V; Gillman, A; Harrington, J; Hew, M; Bardin, P; Peters, M; Reynolds, PN; Langton, D; Baraket, M; Bowden, JJ; Bowler, S; Chien, J; Chung, LP; Farah, CS; Grainge, C; Jenkins, C; Katsoulotos, GP; Lee, J; Radhakrishna, N; Reddel, HK; Rimmer, J; Sivakumaran, P; Wark, PAB; Gibson, PG

Gibson, PG (corresponding author), Univ Newcastle, Prior Res Ctr Hlth Lungs, Univ Dr, Newcastle, NSW 2308, Australia.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021; 9 (7): 2715

Abstract

BACKGROUND: Oral corticosteroids (OCS) carry serious health risks. Innovative treatment options are required to reduce excessive exposure and promote ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索